Home > Insider Trading > Filing (0001477932-21-001163)

Filing Details

Accession Number:: 0001477932-21-001163
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-03-02 13:23:11
Reporting Period:: 2021-01-22

Accepted Time:: 2021-03-02 13:23:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1443863	Biocorrx Inc.	BICX	Services-Specialty Outpatient Facilities, Nec (8093)	900967447

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1539788	C. Louis Lucido	C/O Biocorrx Inc. 2390 East Orangewood, Suite 500 Anaheim CA 92806		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Acquisiton	2021-01-22	2,000	$1.44	63,630	No	4	P	Direct
Common Stock, Par Value $0.001 Per Share	Acquisiton	2021-02-26	562,500	$2.00	562,500	No	4	P	Indirect	By Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	By Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	200,000	Indirect	By Louis and Carolyn Lucido CRT LLC

Footnotes

The reported price in Column 4 is a weighted average price. These shares were purchased in three transactions at prices ranging from $1.40 to $1.45 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Due to a clerical error in the Form 4 filed by the reporting person on January 5, 2021, the Form 4 incorrectly stated that the reporting person owned 261,926 shares directly. In fact, as of January 5, 2021, the reporting person owned 61,630 shares directly and 200,000 shares indirectly through Louis and Carolyn Lucido CRT LLC (the "LLC"). The difference of 296 shares was due to the aforesaid clerical error, which the reporting person did not discover until now. This Form 4 corrects the aforesaid errors in Table 1, Column 5. Following the reported transactions on January 22, 2021, the reporting person currently owns 63,630 shares directly.
These shares were issued to the Louis C Lucido and Carolyn M. Lucido, or their Successors, as Trustee of the Lucido Family Trust, Dated May 23, 2017 (the "Lucido Trust") pursuant to a subscription agreement by and between BioCorRx Inc. and the Lucido Trust dated February 16, 2021, fully executed on February 23, 2021, and paid for on February 26, 2020. The Reporting Person may be deemed to have investment power over the Lucido Trust.
Due to a clerical error in the Form 4 filed by the reporting person on January 5, 2021, the Form 4 incorrectly stated that the reporting person owned 261,926 shares directly. In fact, as of January 5, 2021, the reporting person owned 61,630 shares directly and 200,000 shares indirectly through the LLC. This Form 4 corrects the aforesaid errors in Table 1, Column 5. The reporting person's holdings with respect to the shares held by the LLC have not changed since April 3, 2019.